BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22669480)

  • 1. Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer.
    Ruckova E; Muller P; Nenutil R; Vojtesek B
    Cell Mol Biol Lett; 2012 Sep; 17(3):446-58. PubMed ID: 22669480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances.
    Muller P; Ruckova E; Halada P; Coates PJ; Hrstka R; Lane DP; Vojtesek B
    Oncogene; 2013 Jun; 32(25):3101-10. PubMed ID: 22824801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+/S100 proteins act as upstream regulators of the chaperone-associated ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein).
    Shimamoto S; Kubota Y; Yamaguchi F; Tokumitsu H; Kobayashi R
    J Biol Chem; 2013 Mar; 288(10):7158-68. PubMed ID: 23344957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma.
    Kubota H; Yamamoto S; Itoh E; Abe Y; Nakamura A; Izumi Y; Okada H; Iida M; Nanjo H; Itoh H; Yamamoto Y
    Cell Stress Chaperones; 2010 Nov; 15(6):1003-11. PubMed ID: 20617406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the C-terminal domain of Harc for binding to Hsp70 and Hop as well as its response to heat shock.
    Cartledge K; Elsegood C; Roiniotis J; Hamilton JA; Scholz GM
    Biochemistry; 2007 Dec; 46(51):15144-52. PubMed ID: 18052042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Binding of Tetratricopeptide Repeat Proteins to Heat Shock Protein 70 (Hsp70) and Heat Shock Protein 90 (Hsp90) Is Regulated by Affinity and Phosphorylation.
    Assimon VA; Southworth DR; Gestwicki JE
    Biochemistry; 2015 Dec; 54(48):7120-31. PubMed ID: 26565746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.
    Schulz R; Marchenko ND; Holembowski L; Fingerle-Rowson G; Pesic M; Zender L; Dobbelstein M; Moll UM
    J Exp Med; 2012 Feb; 209(2):275-89. PubMed ID: 22271573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATPase activity and ATP-dependent conformational change in the co-chaperone HSP70/HSP90-organizing protein (HOP).
    Yamamoto S; Subedi GP; Hanashima S; Satoh T; Otaka M; Wakui H; Sawada K; Yokota S; Yamaguchi Y; Kubota H; Itoh H
    J Biol Chem; 2014 Apr; 289(14):9880-6. PubMed ID: 24535459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
    Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L
    PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AQP2 Abundance is Regulated by the E3-Ligase CHIP Via HSP70.
    Centrone M; Ranieri M; Di Mise A; Berlingerio SP; Russo A; Deen PMT; Staub O; Valenti G; Tamma G
    Cell Physiol Biochem; 2017; 44(2):515-531. PubMed ID: 29145196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The assembly and intermolecular properties of the hsp70-Hop-hsp90 molecular chaperone complex.
    Hernández MP; Sullivan WP; Toft DO
    J Biol Chem; 2002 Oct; 277(41):38294-304. PubMed ID: 12161444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of the hsp70-binding protein BAG-1 on glucocorticoid receptor folding by the hsp90-based chaperone machinery.
    Kanelakis KC; Morishima Y; Dittmar KD; Galigniana MD; Takayama S; Reed JC; Pratt WB
    J Biol Chem; 1999 Nov; 274(48):34134-40. PubMed ID: 10567384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells.
    Schaefer S; Svenstrup TH; Guerra B
    PLoS One; 2017; 12(5):e0177706. PubMed ID: 28542269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ErbB2 degradation mediated by the co-chaperone protein CHIP.
    Zhou P; Fernandes N; Dodge IL; Reddi AL; Rao N; Safran H; DiPetrillo TA; Wazer DE; Band V; Band H
    J Biol Chem; 2003 Apr; 278(16):13829-37. PubMed ID: 12574167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.
    Li D; Marchenko ND; Schulz R; Fischer V; Velasco-Hernandez T; Talos F; Moll UM
    Mol Cancer Res; 2011 May; 9(5):577-88. PubMed ID: 21478269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hsp70-Hsp90 go-between Hop/Stip1/Sti1 is a proteostatic switch and may be a drug target in cancer and neurodegeneration.
    Bhattacharya K; Picard D
    Cell Mol Life Sci; 2021 Dec; 78(23):7257-7273. PubMed ID: 34677645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The switch from client holding to folding in the Hsp70/Hsp90 chaperone machineries is regulated by a direct interplay between co-chaperones.
    Dahiya V; Rutz DA; Moessmer P; Mühlhofer M; Lawatscheck J; Rief M; Buchner J
    Mol Cell; 2022 Apr; 82(8):1543-1556.e6. PubMed ID: 35176233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balance between folding and degradation for Hsp90-dependent client proteins: a key role for CHIP.
    Kundrat L; Regan L
    Biochemistry; 2010 Sep; 49(35):7428-38. PubMed ID: 20704274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the Hsp90 cochaperone cyclophilin 40 with Hsc70.
    Carrello A; Allan RK; Morgan SL; Owen BA; Mok D; Ward BK; Minchin RF; Toft DO; Ratajczak T
    Cell Stress Chaperones; 2004; 9(2):167-81. PubMed ID: 15497503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hsp70 interacting protein Hip does not affect glucocorticoid receptor folding by the hsp90-based chaperone machinery except to oppose the effect of BAG-1.
    Kanelakis KC; Murphy PJ; Galigniana MD; Morishima Y; Takayama S; Reed JC; Toft DO; Pratt WB
    Biochemistry; 2000 Nov; 39(46):14314-21. PubMed ID: 11087380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.